» Articles » PMID: 37101811

Inhibition of 3-Hydroxykynurenine Transaminase from and : A Mosquito-Specific Target to Combat the Transmission of Arboviruses

Overview
Specialty Biochemistry
Date 2023 Apr 27
PMID 37101811
Authors
Affiliations
Soon will be listed here.
Abstract

Arboviral infections such as Zika, chikungunya, dengue, and yellow fever pose significant health problems globally. The population at risk is expanding with the geographical distribution of the main transmission vector of these viruses, the mosquito. The global spreading of this mosquito is driven by human migration, urbanization, climate change, and the ecological plasticity of the species. Currently, there are no specific treatments for -borne infections. One strategy to combat different mosquito-borne arboviruses is to design molecules that can specifically inhibit a critical host protein. We obtained the crystal structure of 3-hydroxykynurenine transaminase (AeHKT) from , an essential detoxification enzyme of the tryptophan metabolism pathway. Since AeHKT is found exclusively in mosquitoes, it provides the ideal molecular target for the development of inhibitors. Therefore, we determined and compared the free binding energy of the inhibitors 4-(2-aminophenyl)-4-oxobutyric acid (4OB) and sodium 4-(3-phenyl-1,2,4-oxadiazol-5-yl)butanoate (OXA) to AeHKT and AgHKT from , the only crystal structure of this enzyme previously known. The cocrystallized inhibitor 4OB binds to AgHKT with of 300 μM. We showed that OXA binds to both AeHKT and AgHKT enzymes with binding energies 2-fold more favorable than the crystallographic inhibitor 4OB and displayed a 2-fold greater residence time τ upon binding to AeHKT than 4OB. These findings indicate that the 1,2,4-oxadiazole derivatives are inhibitors of the HKT enzyme not only from but also from .

Citing Articles

Molecular docking and molecular dynamics simulation studies of inhibitor candidates against 3-hydroxykynurenine transaminase and implications on vector control.

Adedeji E, Ogunlana O, Oduselu G, Koenig R, Adebiyi E, Soremekun O Heliyon. 2025; 11(1):e41633.

PMID: 39866405 PMC: 11759636. DOI: 10.1016/j.heliyon.2025.e41633.


Exploring the Larvicidal and Adulticidal Activity against of Essential Oil from .

Silva J, Oliveira A, Franca L, da Cruz J, Amaral A Molecules. 2024; 29(10).

PMID: 38792102 PMC: 11124082. DOI: 10.3390/molecules29102240.

References
1.
Vauquelin G, Van Liefde I . Slow antagonist dissociation and long-lasting in vivo receptor protection. Trends Pharmacol Sci. 2006; 27(7):356-9. DOI: 10.1016/j.tips.2006.05.001. View

2.
Maciel L, Barbosa A, de Alencar-Filho E, Soares T, Dos Anjos J . A second generation of 1,2,4-oxadiazole derivatives with enhanced solubility for inhibition of 3-hydroxykynurenine transaminase (HKT) from . RSC Med Chem. 2021; 12(2):222-236. PMC: 8127416. DOI: 10.1039/d0md00305k. View

3.
Chen V, Arendall 3rd W, Headd J, Keedy D, Immormino R, Kapral G . MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr. 2010; 66(Pt 1):12-21. PMC: 2803126. DOI: 10.1107/S0907444909042073. View

4.
Thomas S, Endy T . Critical issues in dengue vaccine development. Curr Opin Infect Dis. 2011; 24(5):442-50. DOI: 10.1097/QCO.0b013e32834a1b0b. View

5.
Brady O, Gething P, Bhatt S, Messina J, Brownstein J, Hoen A . Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis. 2012; 6(8):e1760. PMC: 3413714. DOI: 10.1371/journal.pntd.0001760. View